SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
2Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science of St. Michael’s Hospital, Toronto, ON, Canada.
3Toronto Platelet Immunobiology Group, Toronto, ON, Canada.
4Department of Physiology, University of Toronto, Toronto, ON, Canada.
5CCOA Therapeutics Inc., Toronto, ON, Canada.
6Canadian Blood Services Centre for Innovation, Toronto, ON, Canada.
7The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
8Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
9Advanced Pharmaceutics & Drug Delivery Laboratory, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
10Department of Medical Microbiology and Infectious Disease, Sunnybrook Health Science Centre, Toronto, ON, Canada.
11Department of Medicine, University of Toronto, Toronto, ON, Canada.
12Division of Cardiology, St. Michael's Hospital, Toronto, ON, Canada.
13Department of Anesthesiology and Pain Medicine and Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
14Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
15Department of Surgery, University of Toronto, Toronto, ON, Canada.
收起